Altana Licenses Spotfire DecisionSite Software

Nov 01, 2004

NEW YORK, Nov. 1 (GenomeWeb News) - Spotfire today said that Altana Pharma has licensed its Spotfire DecisionSite software worldwide for research, lead discovery, and clinical safety in four separate labs.

The drug maker currently uses the software in functional genomics and lead discovery research, Spotfire said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Sharing, But Kinda Sorta

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

This Week in Science

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

Structural Biologist Leads India's CSIR

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

Upward of One Hundred

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Main menu